History of stroke or TIA within the previous 3 months or significant neurological damage that would impair the ability to respond to or detect improvement with the vagal nerve stimulation.Acute myocardial infarction (MI), variant angina pectoris, unstable angina or acute coronary syndrome in the previous one month.Presence of a life threatening condition or disease other than heart failure, that is likely to lead to death within 6 months.Subjects with CRT devices may be included in the trial provided they have had CRT for at least 12 months.Subject agrees to attend all followup evaluations. Subject must sign an approved informed consent form.Females of childbearing age may be included if an acceptable contraception measure is used. The subject is a male or postmenopausal female.The left ventricular end diastolic diameter, per site measurement, should be between 50 and 80 mm.LVEF ≤ 40% per site measurement within three months before enrollment.On stable optimally uptitrated medical therapy recommended according to current guidelines as standard of care for heart failure therapy.Subjects should be predominately in sinus rhythm at the time of enrollment.Chronic symptomatic heart failure in New York Heart Association functional class III.Why Should I Register and Submit Results?.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |